NASDAQ: ABIOArca Biopharma Inc Stock Ownership - Who owns Arca Biopharma?
Insider buying vs selling
Have Arca Biopharma Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ABIO insiders and whales buy or sell their stock.
ABIO Shareholders
What type of owners hold Arca Biopharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jon Sakoda | 70.49% | 10,221,465 | $32.81M | Insider |
| Ravi Viswanathan | 70.49% | 10,221,465 | $32.81M | Insider |
| Peter W. Sonsini | 70.49% | 10,221,465 | $32.81M | Insider |
| Harry R. Weller | 70.49% | 10,221,465 | $32.81M | Insider |
| Scott D. Sandell | 70.49% | 10,221,465 | $32.81M | Insider |
| David M. Mott | 70.49% | 10,221,465 | $32.81M | Insider |
| Joshua Makower | 70.49% | 10,221,465 | $32.81M | Insider |
| Krishna Kittu Kolluri | 70.49% | 10,221,465 | $32.81M | Insider |
| Anthony A. Florence Jr. | 70.49% | 10,221,465 | $32.81M | Insider |
| Forest Baskett | 70.49% | 10,221,465 | $32.81M | Insider |
ABIO vs Biotech Stocks
Arca Biopharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.